New nitrogen mustards structurally related to (L)-carnitine

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 3, 2003, Pages 325-334

  Faissat, Ludovic ^a   Martin, Katja ^a   Chavis, Claude ^a   Montéro, Jean Louis ^a   Lucas, Marc ^a  

^a INSTITUT CHARLES GERHARDT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 [4 BIS(2 CHLOROETHYL)AMINO]PHENYL]BUTYRYLOXY 4 [N,N BIS(2 CHLOROETHYL)AMINO]BUTYRIC ACID; 3 ACETOXY 4 [N,N BIS(2 CHLOROETHYL)AMINO]BUTYRIC ACID; 3 CAPRYLOYLOXY 4 [N,N BIS(2 CHLOROETHYL)AMINO]BUTYRIC ACID; 3 HYDROXY 4 [N,N BIS(2 CHLOROETHYL)AMINO]BUTYRIC ACID; 3 PHENYLACETYLOXY 4 [N,N BIS(2 CHLOROETHYL)AMINO]BUTYRIC ACID; 3 PROPIONYLOXY 4 [N,N BIS(2 CHLOROETHYL)AMINO]BUTYRIC ACID; CARNITINE DERIVATIVE; CHLORAMBUCIL; CHLORMETHINE DERIVATIVE; DI TERT BUTYLMALATE; MALIC ACID DERIVATIVE; MELPHALAN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; ESTERIFICATION; HUMAN; HUMAN CELL; IC 50; LIPOPHILICITY; STEREOCHEMISTRY;

ANTINEOPLASTIC AGENTS, ALKYLATING; CARNITINE; HUMANS; INHIBITORY CONCENTRATION 50; MALATES; NITROGEN MUSTARD COMPOUNDS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

BRASSICACEAE;

EID: 0037294469     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00458-3     Document Type: Article

References (48)

1. Foye W.O. Cancer Chemotherapeutic Agents. 1995;Massachusetts College of Pharmacy and Allied Health Sciences, Washington, DC.
2. Gniazdowski M., Cera C. Chem. Rev. 96:1996;619.
3. Rajski S.R., Williams R.M. Chem. Rev. 98:1998;2723.
4. Fritz, I. B. Current Concepts in Carnitine Research; CRC: Boca Raton, Florida, 1992.
5. Ferrari R., DiMauro S., Sherwood G. L-Carnitine and its Role in Medicine: From Function to Therapy. 1992;Academic, San Diego.
6. Ramsay R.R., Gandfour R.D., van der Leij F.R. Biochim. Biophys. Acta. 1546:2001;21.
7. Cavalli L.R., Liang B.C. Mutation Res. Mol. Mechanisms Mutagenesis. 398:1998;19.
8. Dacaudin D., Marzo I., Brenner C., Kroemer G. Int. J. Oncol. 12:1998;141.
9. Costantini P., Jacotot E., Decaudin D., Kroemer G. J. Natl. Cancer Inst. 92:2000;1042.
10. Grad J.M., Cepero E., Boise L.H. Drug Resist. Updates. 4:2001;85.
11. Lewis P.D., Baxter P.W., Griffiths A.P., Parry J.M., Skibinski D.O.F. J. Pathol. 192:2000;562.
12. Yokogawa K., Miya K., Tamai I., Higashi Y., Nomura M., Miyamoto K.-I., Tsuji A. J. Pharm. Pharmacol. 51:1999;935.
13. Boots S.G., Boots M.R. J. Pharm. Sci. 64:1975;1262.
14. Pavlov S., Bogavac M., Arsenijevic V. Bull. Soc. Chim. Fr. 1974;2985.
15. Kuo C.H., Robichaud A.J., Rew D.J., Bergstrom J.D., Berger G.D. Bioorg. Med. Chem. Lett. 4:1994;1591.
16. Sefkow M. Tetrahedron: Asymmetry. 12:2001;987.
17. Alpegiani M., Hanessian S. J. Org. Chem. 52:1987;278.
18. Gao Y., Zepp C.M. Tetrahedron Lett. 32:1991;3155.
19. Rho H.-S. Synth. Commun. 28:1998;843.
20. Jang D.O., Song S.H. Tetrahedron Lett. 41:2000;247.
21. Uray G., Lindner W. Tetrahedron. 44:1988;4357.
22. Corey E.J., Winter R.A.E. J. Am. Chem. Soc. 85:1963;2677.
23. Gao Y., Sharpless K.B. J. Am. Chem. Soc. 110:1988;7538.
24. Faissat L., Chavis C., Montero J.-L., Lucas M. J. Chem. Soc., Perkin Trans. 1. 2002;1253.
25. Kim B.M., Sharpless K.B. Tetrahedron Lett. 30:1989;655.
26. Saito S., Hasegawa T., Inaba M., Nishida R., Fujii T., Nomizu S., Moriwake T. Chem. Lett. 1984;1389.
27. Saito S., Ishikawa T., Kuroda A., Koga K., Moriwake T. Tetrahedron. 48:1992;4067.
28. Bellamy F.D., Bondoux M., Dodey P. Tetrahedron Lett. 31:1990;7323.
29. Degenhardt C.R. J. Org. Chem. 45:1980;2763.
30. Bianchi D., Cabri W., Cesti P., Francalanci F., Ricci M. J. Org. Chem. 53:1988;104.
31. Larchevêque M., Henrot S. Tetrahedron Lett. 28:1987;1781.
32. Larchevêque M., Henrot S. Tetrahedron. 46:1990;4277.
33. Liu P., Panek J.S. J. Am. Chem. Soc. 122:2000;1235.
34. Tokunaga M., Larrow J.F., Kakiuchi F., Jacobsen E.N. Science. 277:1997;936.
35. Farnum D.G., Johnson J.R., Hess R.E., Marshall T.B., Webster B. J. Am. Chem. Soc. 87:1965;5191.
36. Truce W.E., Bailey P.S. Jr. J. Org. Chem. 34:1969;1341.
37. Jarowicki K., Kwiatkowski S. Monatsh. Chem. 116:1985;141.
38. Qin D., Byun H.-S., Bittman R. J. Am. Chem. Soc. 121:1999;662.
39. Chen K.M., Joullié M.M. Tetrahedron Lett. 25:1984;393.
40. Matsuura F., Hamada Y., Shioiri T. Tetrahedron. 50:1993;265.
41. Chauvel E.N., Coric P., Llorens-Cortès C., Wilk S., Roques B.P., Fournié-Zaluski M.-C. J. Med. Chem. 37:1994;1339.
42. Hansch C. Acc. Chem. Res. 2:1969;232.
43. Giraud I., Rapp M., Maurizis J.-C., Madelmont J.-C. J. Med. Chem. 45:2002;2116.
44. Ferrandina G., Melichar B., Loercher A., Verschraegen C.F., Kudelka A.P., Edwards C.L., Scambia G., Kavanagh J.J., Abbruzzese J.L., Freedman R.S. Cancer Res. 57:1997;4309.
45. Vasse M., Thibout D., Paysant J., Legrand E., Soria C., Crépin M. Br. J. Cancer. 84:2001;802.
46. Watanabe M., Sugano S., Imai J., Yoshida K., Onodera R., Amin M.R., Uchida K., Yamaguchi R., Tateyama S. Res. Vet. Sci. 70:2001;27.
47. Ziegler H.J., Bruckner P., Binon F. J. Org. Chem. 32:1967;3989.
48. Evrard A., Vian L., Aubert C., Cano J.P. Cell Biol. Toxicol. 12:1996;345.